Deaths Associated with Respiratory Syncytial and Influenza Viruses among Persons ≥5 Years of Age in HIV-Prevalent Area, South Africa, 1998–20091 - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC
Volume 21, Number 4—April 2015
CME ACTIVITY - Research
Deaths Associated with Respiratory Syncytial and Influenza Viruses among Persons ≥5 Years of Age in HIV-Prevalent Area, South Africa, 1998–20091
Influenza virus and respiratory syncytial virus (RSV) infections cause substantial numbers of illness and deaths globally each year; the highest rates are in young children and persons >65 years of age (1–4). However, national estimates of deaths caused by these infections remain scarce in Africa.
Available data suggest that the severity of influenza and RSV illness is higher among HIV-positive persons (5–11). During 2009 in South Africa, ≈5.1 million HIV-positive persons >5 years of age were reported (12). The highest prevalence was in the 20–44-year age group, among whom HIV prevalence increased from 10% in 1998 to 24% in 2009. Coverage with highly active antiretroviral therapy (HAART) among HIV-positive persons slowly increased from 2004 to reach a plateau of ≈14% in 2009 (12). The lowest reported occurrence of HIV infection in the country was in persons >75 years of age; data showed a 0.6% prevalence and 26% HAART coverage for this group in 2009 (12). Pneumonia ranked within the top 5 leading causes of death among persons >15 years of age in South Africa in 2009 (13).
Clarification of the annual number of deaths associated with influenza and RSV in South Africa could assist with the prioritization of interventions. Because influenza virus and RSV infections are rarely confirmed by laboratory diagnosis and related deaths may be attributed to co-morbid conditions or secondary infections, we applied modeling approaches (14) to estimate seasonal and pandemic influenza- and RSV-associated deaths among persons >5 years of age during 1998–2009.
Dr. Stefano Tempia is a veterinary epidemiologist working for the Influenza Division, US Centers for Disease Control and Prevention, and based at the National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa. His research interests are focused on infectious diseases.
- Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178:53–60.
- Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng PY, Steiner C, Hospitalization associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis. 2012;54:1427–36.
- Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86.
- Hardelid P, Pebody R, Adrews N. Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999–2010.Influenza Other Respir Viruses. 2013;7:35–45.
- Moyes J, Cohen C, Pretorius M, Groom M, von Gottberg A, Wolter N, Epidemiology of respiratory syncytial virus–associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010–2011. J Infect Dis. 2013;208(Suppl 3):S217–26.
- Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis.2011;52:219–27.
- Madhi SA, Schoub B, Simmank K, Blackburn N, Klugman KP. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr. 2000;137:78–84.
- Madhi SA, Ramasamy N, Bessellar TG, Saloojee H, Klugman KP. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr Infect Dis J. 2002;21:291–7.
- Ope MO, Katz MA, Aura B, Gikunju S, Njenga MK, Ng’ang’a Z, Risk factors for hospitalized seasonal influenza in rural Western Kenya. PLoS ONE.2011;6:e20111.
- Madhi SA, Kuwanda L, Cutland C, Klugman KP. Five-year Cohort study of hospitalisation for respiratory syncytial virus associated lower respiratory tract infection in African children. J Clin Virol. 2006;36:215–21.
- Cohen C, Moyes J, Tempia S, Groom M, Wakaza S, Pretorius M, Severe influenza-associated lower respiratory tract infection in a high HIV prevalence setting, South Africa, 2009–2011. Emerg Infect Dis. 2013;19:1766–74.
- Actuarial Society of South Africa (ASSA). AIDS and demographic model [cited 2012 Sep 20]. http://aids.actuarialsociety.org.za/ASSA2008-Model-3480.htm
- Statistics South Africa. Mortality and cause of death in South Africa 2009: Findings from death notification. Pretoria, Statistics South Africa, 2009[cited 2013 June 12]. http://www.statssa.gov.za/publications/P03093/P030932009.pdf.
- Tempia S, Walaza S, Viboud C, Cohen AL, Madhi SA, Venter M, Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting—South Africa, 1998–2009. Clin Infect Dis. 2014;58:1241–9.
- Statistics South Africa. Mortality and causes of death in South Africa: findings from death notifications, 1998–2009. Pretoria (South Africa): Statistics South Africa; 2009.
- Statistics South Africa. Population statistics [cited 2012 Sep 21]. http://www.statssa.gov.za/publications/populationstats.asp
- McAnerney JM, Cohen C, Moyes J, Besselaar TG, Buys A, Schoub BD, Twenty-five years of outpatient influenza surveillance in South Africa (1984–2008). J Infect Dis. 2012;206(Suppl1):S153–8.
- Cohen C, Simonsen L, Sample J, Kang JW, Miller M, Madhi SA, Influenza-related mortality among adults aged 25–54 years with AIDS in South Africa and the United States of America. Clin Infect Dis. 2012;55:996–1003.
- Cohen C, Simonsen L, Kang JW, Miller M, McAnerney J, Blumberg L, Elevated influenza-related excess mortality in South African elderly individuals, 1998–2005. Clin Infect Dis. 2010;51:1362–9.
- Nunes B, Viboud C, Machado A, Ringholz C, Rebelo-de-Andrade H, Noqueira P, Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS ONE. 2011;6:e20661.
- Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS ONE. 2012;7:e45051.
- Charu V, Chowell G, Palacio Mejia LS, Echevarría-Zuno S, Borja-Aburto VH, Simonsen L, Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis. 2011;53:985–93.
- van den Wijngaard CC, van Asten L, Koopmans MPG, van Pelt W, Nagelkerke NJD, Wielders CC, Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS ONE. 2012;7:e31197.
- Charu V, Simonsen L, Lustig R, Steiner C, Viboud C. Mortality burden of the 2009–10 influenza pandemic in the United States: improving the timeliness of influenza severity estimates using inpatient mortality records. Influenza Other Respir Viruses. 2013;7:863–71.
- Freitas ARR, Francisco PMSB, Donalisio MR. Mortality associated with influenza in tropics, State of São Paulo, Brazil, from 2002 to 2011: the pre-pandemic, pandemic and post-pandemic periods. Influenza Res Treat. 2013;2013:696274.
- Dawood FS, Juliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling approach. Lancet Infect Dis. 2012;12:687–95.
- Charu V, Simonsen L, Jordan R, Steiner C, Viboud C. Contrasting the impact of influenza and respiratory syncytial virus (RSV) in the US. Proceeding of the incidence, severity and impact of influenza conference. Munich, 5–8 September 2012 [cited 12 June 2013].http://creativestage.nucleusclient.com/isirv/Incidence/Viboud_WEB_Version.pdf
- Kyeyagalire R, Tempia S, Cohen AL, Smith AD, McAnerney JM, Dermaux-Msimang V, Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007–2012. BMC Infect Dis. 2014;14:694.
- Lee N, Lui GC, Wong KT, Li TC, Tse EC, Chan JY, High morbidity and mortality in adults hospitalized for respiratory syncytial virus infection. Clin Infect Dis. 2013;57:1069–77.
- Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, Esen M, Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis. 2014;209:1873–81.
- Bigogo GM, Breiman RF, Feikin DR, Audi AO, Aura B, Cosmas L, Epidemiology of respiratory syncytial virus infection in rural and urban Kenya. J Infect Dis. 2013;208(Suppl 3):S207–16.
- Pretorius M, Tempia S, Walaza S, Cohen A, Moyes J, Hellferscee O, Association of influenza and other respiratory viruses with severe acute respiratory infection and influenza-like illness, relative to healthy controls in South Africa. In: Proceedings of the 8th Options for the Control of Influenza Conference, 5–10 September 2013, Cape Town, South Africa.
- Rowlinson E, Dueger E, Taylor T, Mansour A, Van Beneden C, Abukela M, Incidence and clinical features of respiratory syncytial virus infections in a population-based surveillance site in the Nile Delta Region. J Infect Dis. 2013;208(Suppl 3):S189–96.
- McCracken JP, Prill MM, Arvelo W, Lindblade KA, López MR, Estevez A, Respiratory syncytial virus infection in Guatemala, 2007–2012. J Infect Dis.2013;208(Suppl 3):S197–206.
- Naorat S, Chittaganpitch M, Thamthitiwat S, Henchaichon S, Sawatwong P, Srisaengchai P, Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008–2011. J Infect Dis. 2013;208(Suppl 3):S238–45.
- Walsh EE, Falsey AR. Respiratory syncytial virus infection in adult populations. Infect Disord Drug Targets. 2012;12:98–102.
- Piedra PA, Jewell AM, Cron SG, Atmar RL, Glezen WP. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine. 2003;21:3479–82.
- Pretorius MA, Madhi SM, Cohen C, Naidoo D, Groome M, Moyes J, Respiratory viral co-infections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness—South Africa, 2009–2010. J Infect Dis.2012;206(Suppl 1):S159–65.
- Goldstein E, Viboud C, Charu V, Lipsitch M. Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology.2012;23:829–38.
- Bradshaw D, Pillay-Van Wyk V, Laubscher R, Nojilana B, Groenewald P, Nadine N, Causes of death for South Africa: challenges and possibilities for improvement. South African Medical Research Council [cited 2013 Jun 12]. http://www.mrc.ac.za/bod/cause_death_statsSA.pdf
Suggested citation for this article: Tempia S, Walaza S, Viboud C, Cohen AL, Madhi SA, Venter M, et al. Deaths associated with respiratory syncytial and influenza viruses among persons >5 years of age in HIV-prevalent area, South Africa, 1998–2009. Emerg Infect Dis. 2015 Apr [date cited].http://dx.doi.org/10.3201/eid2103.141033
1Data from this study were presented in part at the Options for the Control of Influenza Conference VIII; 2013 Sep 5–10; Cape Town, South Africa.